Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Background & Aims Information about malignancies that arise in patients after liver transplantation comes from volunteer registry databases and single-center retrospective studies. We analyzed a multi-center, prospectively obtained database to assess the probabilities of and risk factors for de novo malignancies in patients after liver transplantation. Methods We analyzed the National Institute of Diabetes and Digestive and Kidney Diseases’s Liver Transplantation Database of 798 adults that received transplants from April 1990 to June 1994 and long-term follow-up data through January 2003. In this patient population, 171 adult patients developed 271 de novo malignancies. Of these malignancies, 147 were skin related, 29 were hematologic, and 95 were solid organ cancers; we focused on non-skin malignancies. Results The probability of developing any non-skin malignancy was highest in patients with primary sclerosing cholangitis (PSC, 22% at 10 years) or alcohol-related liver disease (ALD, 18% at 10 years); all other diagnoses had a 10% probability. Multivariate analysis indicated that increased age by decade (hazard ratio [HR] 1.33, p=0.01), a history of smoking (HR 1.6, p=0.046), PSC (HR 2.5, p=0.001), and ALD (HR 2.1, p=0.01) were associated with the development of solid malignancies after liver transplantation. The probabilities of death after diagnosis of hematologic and solid malignancy ere 44.0% and 38.0% at one year and 57.6% and 53.1% at 5 years, respectively. Conclusions De novo malignancy primarily affects patients with PSC or ALD, compared to other transplant recipients, with a significant impact on long-term survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gooley, T. A., Leisenring, W., Crowley, J., & Storer, B. E. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19990330)18:6<695::aid-sim60>3.0.co;2-o · Cited by 2,688
High Prevalence of Vitamin D Inadequacy and Implications for Health
Holick, M. F. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.3.353 · Cited by 2,005
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics
Deeb, K. K., Trump, D. L., & Johnson, C. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2196 · Cited by 1,419
Recurrence of Primary Sclerosing Cholangitis Following Liver Transplantation
Graziadei, I. W., Wiesner, R. H., Batts, K. P., Marotta, P. J., LaRusso, N. F., Porayko, M. K., Hay, E. J., Gores, G. J., Charlton, M. R., Ludwig, J., et al. (1999) · Hepatology · doi:10.1002/hep.510290427 · Cited by 375
Self-citationSørensen, H. T., Friis, S., Olsen, J. H., Thulstrup, A. M., Mellemkjær, L., Linet, M., Trichopoulos, D., Vilstrup, H., & Olsen, J. (1998) · Hepatology · doi:10.1002/hep.510280404 · Cited by 328
Increased cancer risk after liver transplantation: a population-based study
Haagsma, E. B., Hagens, V. E., Schaapveld, M., van den Berg, A. P., de Vries, E. G. E., Klompmaker, I. J., Slooff, M. J. H., & Jansen, P. L. M. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00077-5 · Cited by 323
Analysis of causes of death in liver transplant recipients who survived more than 3 years
Pruthi, J., Medkiff, K. A., Esrason, K. T., Donovan, J. A., Yoshida, E. M., Erb, S. R., Steinbrecher, U. P., & Fong, T.-L. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.27084 · Cited by 280
De novo malignancies after liver transplantation: A major cause of late death
Fung, J. J., Jain, A., Kwak, E. J., Kusne, S., Dvorchik, I., & Eghtesad, B. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.28645 · Cited by 202
Jain, A. B., Yee, L. D., Nalesnik, M. A., Youk, A., Marsh, G., Reyes, J., Zak, M., Rakela, J., Irish, W., & Fung, J. J. (1998) · Transplantation · doi:10.1097/00007890-199811150-00014 · Cited by 198
Posttransplantation de novo tumors in liver allograft recipients
Penn, I. (1996) · Liver Transplantation and Surgery · doi:10.1002/lt.500020109 · Cited by 134
De novo tumors after liver transplantation: A single-institution experience
Sanchez, E. Q., Marubashi, S., Jung, G., Levy, M. F., Goldstein, R. M., Molmenti, E. P., Fasola, C. G., Gonwa, T. A., Jennings, L. W., Brooks, B. K., et al. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.29350 · Cited by 123
Liver transplantation and subsequent risk of cancer: Findings from a Canadian cohort study
Jiang, Y., Villeneuve, P. J., Fenton, S. S. A., Schaubel, D. E., Lilly, L. B., & Mao, Y. (2008) · Liver Transplantation · doi:10.1002/lt.21554 · Cited by 118
Late mortality after orthotopic liver transplantation
Rabkin, J. M., Melena, V. D. L., Orloff, S. L., Corless, C. L., Rosen, H. R., & Olyaei, A. J. (2001) · The American Journal of Surgery · doi:10.1016/s0002-9610(01)00595-5 · Cited by 112
Sokol, H., Cosnes, J., Chazouilleres, O., Beaugerie, L., Tiret, E., Poupon, R., & Seksik, P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.3497 · Cited by 97
Smoking Behavior in Liver Transplant Recipients
van der Heide, F., Dijkstra, G., Porte, R. J., Kleibeuker, J. H., & Haagsma, E. B. (2009) · Liver Transplantation · doi:10.1002/lt.21722 · Cited by 95
De novo malignancies following liver transplantation: a case–control study with long‐term follow‐up
Yao, F. Y., Gautam, M., Palese, C., Rebres, R., Terrault, N. A., Roberts, J. P., & Peters, M. G. (2006) · Clinical Transplantation · doi:10.1111/j.1399-0012.2006.00527.x · Cited by 60
Caracterización de los tumores malignos de novo en el trasplante hepático
Catalina-Rodríguez, M. V., de Diego, A., García, Á. S., Escudero, M., Salcedo, M. M., Bañares, R., & Clemente, G. (2003) · Gastroenterología y Hepatología · doi:10.1016/s0210-5705(03)79044-x · Cited by 19
Cited by
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
“470 Journal of Hepatology 201 Significantly higher rates of colorectal cancer have been demonstrated for patients with PSC and inflammatory bowel disease in the post-LT course [450].”
BackgroundInfluentialMartin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
“While tobacco use is common in patients with a history of liver disease, the use of chewing tobacco, which is associated with oropharyngeal malignancies, is not well studied.(56) There are compelling reasons to prohibit all tobacco use in LT candidates, and indeed some programs make cigarette cessation a condition for…”
BackgroundACG Clinical Guideline: Alcoholic Liver Disease
Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S., & Shah, V. H. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.469 · Cited by 835
Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., & Charlton, M. R. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03126.x · Cited by 785
Self-citationLucey, M. R., Terrault, N., Ojo, L., Hay, E. J., Neuberger, J., Blumberg, E., & Teperman, L. W. (2013) · Liver Transplantation · doi:10.1002/lt.23566 · Cited by 544
“Fungal Infections Risk factors for fungal infections after LT include preoperative fungal colonization, massive transfusion requirements (>40 U of blood products), choledochojejunostomy, reoperation, retransplantation, hepatic iron overload, renal replacement therapy, and extended intervals of intensive care immediate…”
BackgroundInfluential
Metadata
- Authors
- Watt, K. D. S., Pedersen, R. A., Kremers, W. K., Heimbach, J. K., Sanchez, W., & Gores, G. J.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 137
- Issue
- 6
- Pages
- 2010-2017
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2171103481
- Cited by
- 268
- References
- 17
- FWCI
- 10.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.